Continuous electroencephalography characteristics and acute symptomatic seizures in COVID-19 patients.
COVID-19
Critical illness
Electroencephalography (EEG)
Seizures
Journal
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
ISSN: 1872-8952
Titre abrégé: Clin Neurophysiol
Pays: Netherlands
ID NLM: 100883319
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
29
05
2020
revised:
27
07
2020
accepted:
14
08
2020
pubmed:
20
9
2020
medline:
11
11
2020
entrez:
19
9
2020
Statut:
ppublish
Résumé
As concerns regarding neurological manifestations in COVID-19 (coronavirus disease 2019) patients increase, limited data exists on continuous electroencephalography (cEEG) findings in these patients. We present a retrospective cohort study of cEEG monitoring in COVID-19 patients to better explore this knowledge gap. Among 22 COVID-19 patients, 19 underwent cEEGs, and 3 underwent routine EEGs (<1 h). Demographic and clinical variables, including comorbid conditions, discharge disposition, survival and cEEG findings, were collected. cEEG was performed for evaluation of altered mental status (n = 17) or seizure-like events (n = 5). Five patients, including 2 with epilepsy, had epileptiform abnormalities on cEEG. Two patients had electrographic seizures without a prior epilepsy history. There were no acute neuroimaging findings. Periodic discharges were noted in one-third of patients and encephalopathic EEG findings were not associated with IV anesthetic use. Interictal epileptiform abnormalities in the absence of prior epilepsy history were rare. However, the discovery of asymptomatic seizures in two of twenty-two patients was higher than previously reported and is therefore of concern. cEEG monitoring in COVID-19 patients may aid in better understanding an epileptogenic potential of SARS-CoV2 infection. Nevertheless, larger studies utilizing cEEG are required to better examine acute epileptic risk in COVID-19 patients.
Identifiants
pubmed: 32949985
pii: S1388-2457(20)30443-0
doi: 10.1016/j.clinph.2020.08.003
pmc: PMC7448875
mid: NIHMS1629980
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2651-2656Subventions
Organisme : NINDS NIH HHS
ID : R01 NS097719
Pays : United States
Informations de copyright
Copyright © 2020 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Am J Hematol. 2020 Jul;95(7):E156-E158
pubmed: 32267008
J Clin Neurophysiol. 2018 Jul;35(4):325-331
pubmed: 29677014
Crit Care Med. 2009 Jun;37(6):2051-6
pubmed: 19384197
Epilepsia. 2013 Sep;54 Suppl 6:28-9
pubmed: 24001066
Ann Clin Transl Neurol. 2019 Nov;6(11):2230-2239
pubmed: 31657134
Int J Infect Dis. 2020 May;94:55-58
pubmed: 32251791
Seizure. 2020 May;78:109-112
pubmed: 32344366
Clin Neurol Neurosurg. 2020 Jul;194:105921
pubmed: 32422545
JAMA Neurol. 2013 Oct;70(10):1288-95
pubmed: 23921464
N Engl J Med. 2020 May 14;382(20):e60
pubmed: 32343504
Neurocrit Care. 2020 May 28;:
pubmed: 32462412
Neurology. 2012 Nov 6;79(19):1951-60
pubmed: 23035068
Epilepsia Open. 2020 May 17;5(2):314-324
pubmed: 32537529
JAMA Neurol. 2017 Feb 1;74(2):181-188
pubmed: 27992625
J Clin Neurophysiol. 2013 Feb;30(1):1-27
pubmed: 23377439
Epilepsia. 2001 Sep;42(9):1212-8
pubmed: 11580774
Epilepsia. 2020 Jun;61(6):e49-e53
pubmed: 32304092
J Clin Neurophysiol. 2016 Aug;33(4):303-7
pubmed: 27482788
Brain Behav Immun. 2020 Jul;87:18-22
pubmed: 32240762
JAMA Neurol. 2020 Jun 1;77(6):683-690
pubmed: 32275288
Neurology. 2004 May 25;62(10):1743-8
pubmed: 15159471